Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,734 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 4,260 of 4,734    |
|    =?UTF-8?B?4oqZ77y/4oqZ?= to All    |
|    Court says patients can sue drug compani    |
|    21 Aug 16 14:27:43    |
      From: judgebean23x@gmail.com              Court says patients can sue drug companies for fraud                      By Howard Fischer, Capitol Media Services | Updated 4 months ago               PHOENIX -- In a major victory for patients, the Arizona Court of Appeals ruled       Thursday they can sue prescription drug companies for consumer fraud.               Shattering their own precedents, the judges acknowledged that such lawsuits       have not been allowed before in Arizona under the presumption that the drug       company's only obligation is to provide the full list of complications and       side effects to the doctors        who are prescribing the drug. The premise was that patients do not need that       information.               But Judge John Gemmill, writing for the unanimous court, said that rule no       longer has validity because of how manufacturers now are marketing their       products.               "Prescription medication is often advertised and sold to consumers in a manner       similar to other consumer goods," he said.               Gemmill acknowledged that patients cannot get these drugs absent a       prescription written by a doctor. But he said this is no longer the one-way       discussion it used to be.               "Consumers discuss medications with their medical providers and may express       preferences based on advertising," Gemmill wrote. And he said patients have to       decide whether to buy and actually use a drug even after getting a       prescription.               "As a result, consumers may be deceived through fraudulent misrepresentations       in connection with the sale of prescription drugs just as in the sale of       traditional consumer goods," the judge explained. And that, he said, means the       state's Consumer Fraud        Act applies to the sale and advertising of prescription drugs.               "Consumers are regularly presented with advertisements for medications to       treat a variety of symptoms, prompting them to ask, encourage, and even       pressure their medical providers to prescribe these brand-name medications,"       the judge wrote. And he said        Internet sites and medical databases give consumers access to both       manufacturer-provided and third-party information about drugs.               "A physician no longer is necessarily the consumer's sole source of       information about the effects, benefits, and risks of the medication he or she       takes," Gemmill wrote.               What all that means, the judge said, is a manufacturer should not be shielded       from liability.               "Otherwise a consumer may be left without recourse against a manufacturer in a       situation where an adequate warning to a prescribing physician is undermined       or negated by the flawed or incomplete representations of the manufacturer to       the consumer," he        said.               The case involves Solodyn, an oral antibiotic manufactured by Scottsdale-based       Medicis Pharmaceutical Co.               In 2008, Amanda Watts, a minor at the time, got a prescription for the drug       from a doctor to treat chronic acne. She used the drug for 20 weeks.               When she returned to the same doctor two years later, she got a new       prescription for Solodyn and took it for another 20 weeks.               Before using the drug, she got two informational publications providing       details. Neither disclosed any link between Solodyn use and the development of       autoimmune disorders.               But the company, in information available to the doctor, warns of lupus-like       dyndrome and autoimmune hepatitis from "long-term" use of the drug. And that       information tells doctors they should inform patients of symptoms that might       develop that should        cause them to immediately stop using the drug and seek medical help.               In late 2010 Watts was hospitalized with drug-induced lupus and drug-induced       hepatitis, both of which she alleges are side effects of her use of Solodyn.       While she has recovered from the hepatitis, doctors say she may suffer from       lupus the rest of her        life.               A trial judge threw out her consumer fraud lawsuit. But Gemmill said that was       wrong.               He said the Arizona law prohibits "any deception, deceptive or unfair act or       practice, fraud, false promise or misrepresentation" in connection with "the       sale or advertisement of any merchandise." And Gemmill said prescription drugs       are merchandise.               More to the point, he said it's the kind of merchandise that is advertised and       sold just like any other consumer good.               The court acknowledged that Watts' physician had access to all the       information. But Gemmill said that does not take the manufacturer off the hook       given the marketing done directly to consumers.               There was no immediate response from the attorney for the drug company.                             http://m.yumasun.com/news/court-says-patients-can-sue-drug-compa       ies-for-fraud/article_e60a23e8-a838-11e4-9af7-f3203e4a9ef1.html?mode=jqm              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca